KEGG   DRUG: D03247Help
Entry
D03247                      Drug                                   

Name
Lenograstim (genetical recombination) (JP16);
Lenograstim (USAN/INN);
Neutrogin (TN)
Activity
Antineutropenic;
Hematopoietic stimulant [DS:H00100]
Remark
Therapeutic category: 
ATC code: 
Comment
recombinant G-CSF [HSA:1440] [KO:K05423]
Target
granulocyte colony stimulating factor (G-CSF) receptor agonist [HSA:1441] [KO:K05061]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  Jak-STAT signaling pathway  
 
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L03 IMMUNOSTIMULANTS
   L03A IMMUNOSTIMULANTS
    L03AA Colony stimulating factors
     L03AA10 Lenograstim
      D03247  Lenograstim (genetical recombination) (JAN); Lenograstim (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  33  Blood and body fluid agents
   339  Miscellaneous
    3399  Others
     D03247  Lenograstim (genetical recombination) (JP16); Lenograstim (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  Class I cytokine receptors (hematopoietin family receptors)
   granulocyte colony stimulating factor (G-CSF) receptor
    Lenograstim
     D03247  Lenograstim (genetical recombination) (JAN); Lenograstim (USAN/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D03247  Lenograstim (genetical recombination)
BRITE hierarchy
Other DBs
CAS: 
135968-09-1
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system